| Year |
Citation |
Score |
| 2021 |
Sharma A, Almasan A. Autophagy and PTEN in DNA damage-induced senescence. Advances in Cancer Research. 150: 249-284. PMID 33858598 DOI: 10.1016/bs.acr.2021.01.006 |
0.794 |
|
| 2020 |
Kapoor I, Bodo J, Hill BT, Hsi ED, Almasan A. Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance. Cell Death & Disease. 11: 941. PMID 33139702 DOI: 10.1038/s41419-020-03144-y |
0.323 |
|
| 2020 |
Sharma A, Almasan A. USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 21. PMID 32887472 DOI: 10.3390/Ijms21176383 |
0.808 |
|
| 2020 |
Zhang F, Lou L, Peng B, Song X, Reizes O, Almasan A, Gong Z. Nudix hydrolase NUDT16 regulates 53BP1 protein by reversing 53BP1 ADP-ribosylation. Cancer Research. PMID 31911551 DOI: 10.1158/0008-5472.Can-19-2205 |
0.643 |
|
| 2019 |
Kapoor I, Li Y, Sharma A, Zhu H, Bodo J, Xu W, Hsi ED, Hill BT, Almasan A. Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies. Cell Death & Disease. 10: 924. PMID 31801949 DOI: 10.1038/S41419-019-2158-0 |
0.815 |
|
| 2019 |
Sharma A, Alswillah T, Kapoor I, Debjani P, Willard B, Summers MK, Gong Z, Almasan A. USP14 is a deubiquitinase for Ku70 and critical determinant of non-homologous end joining repair in autophagy and PTEN-deficient cells. Nucleic Acids Research. PMID 31740976 DOI: 10.1093/Nar/Gkz1103 |
0.832 |
|
| 2019 |
La Belle Flynn A, Calhoun BC, Sharma A, Chang JC, Almasan A, Schiemann WP. Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression. Nature Communications. 10: 3668. PMID 31413316 DOI: 10.1038/S41467-019-11640-9 |
0.79 |
|
| 2019 |
Qian M, Almasan A, Gürkan-Çavusoglu E. Abstract 686: Quantitative analysis of the role of homologous recombination in response to radiotherapy for prostate cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-686 |
0.605 |
|
| 2018 |
Sharma A, Almasan A. Autophagy as a mechanism of Apo2L/TRAIL resistance. Cancer Biology & Therapy. 1-8. PMID 30067424 DOI: 10.1080/15384047.2018.1472191 |
0.833 |
|
| 2018 |
Sharma A, Alswillah T, Singh K, Chatterjee P, Willard B, Venere M, Summers MK, Almasan A. USP14 regulates DNA damage repair by targeting RNF168-dependent ubiquitination. Autophagy. PMID 29995557 DOI: 10.1080/15548627.2018.1496877 |
0.829 |
|
| 2018 |
Li Y, Kapoor I, Zhu H, Hill BT, Xu W, Almasan A. Abstract 2857: PI3K/AKT activation in de novo and acquired resistance to ibrutinib in lymphoid malignancies Cancer Research. 78: 2857-2857. DOI: 10.1158/1538-7445.Am2018-2857 |
0.69 |
|
| 2017 |
Zhu H, Almasan A. Development of venetoclax for therapy of lymphoid malignancies. Drug Design, Development and Therapy. 11: 685-694. PMID 28331288 DOI: 10.2147/Dddt.S109325 |
0.689 |
|
| 2017 |
Qian M, Almasan A, Gürkan-Çavusoglu E. Abstract 4533:In silicoanalysis of enhanced radiosensitivity in radiation treatment combined with androgen deprivation therapy for prostate cancer Cancer Research. 77: 4533-4533. DOI: 10.1158/1538-7445.Am2017-4533 |
0.615 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin J, Abeliovich H, Arozena AA, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... Almasan A, et al. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Autophagy. 12: 443-443. PMID 26902590 DOI: 10.1080/15548627.2016.1147886 |
0.576 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... Almasan A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.65 |
|
| 2016 |
Qian M, Almasan A, Gurkan-Cavusoglu E. Abstract 2707: Quantitative analysis of the role of androgen receptor in radiation treatment for prostate cancer Cancer Research. 76: 2707-2707. DOI: 10.1158/1538-7445.Am2016-2707 |
0.61 |
|
| 2015 |
Singh V, Gupta D, Almasan A. Development of Novel Anti-Cd20 Monoclonal Antibodies and Modulation in Cd20 Levels on Cell Surface: Looking to Improve Immunotherapy Response. Journal of Cancer Science & Therapy. 7: 347-358. PMID 27413424 DOI: 10.4172/1948-5956.1000373 |
0.601 |
|
| 2015 |
Al-Harbi S, Choudhary GS, Ebron JS, Hill BT, Vivekanathan N, Ting AH, Radivoyevitch T, Smith MR, Shukla GC, Almasan A. miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies. Molecular Cancer. 14: 185. PMID 26537004 DOI: 10.1186/S12943-015-0460-8 |
0.693 |
|
| 2015 |
Choudhary GS, Tat TT, Misra S, Hill BT, Smith MR, Almasan A, Mazumder S. Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics. Oncotarget. 6: 16912-25. PMID 26219338 DOI: 10.18632/Oncotarget.4857 |
0.691 |
|
| 2015 |
Chatterjee P, Choudhary GS, Alswillah T, Xiong X, Heston WD, Magi-Galluzzi C, Zhang J, Klein EA, Almasan A. The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition. Molecular Cancer Therapeutics. 14: 1896-906. PMID 26026052 DOI: 10.1158/1535-7163.Mct-14-0865 |
0.698 |
|
| 2015 |
Choudhary GS, Al-Harbi S, Mazumder S, Hill BT, Smith MR, Bodo J, Hsi ED, Almasan A. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies. Cell Death & Disease. 6: e1593. PMID 25590803 DOI: 10.1038/Cddis.2014.525 |
0.713 |
|
| 2015 |
Choudhary GS, Al-Harbi S, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods in Molecular Biology (Clifton, N.J.). 1219: 1-9. PMID 25308257 DOI: 10.1007/978-1-4939-1661-0_1 |
0.69 |
|
| 2015 |
Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Gupta S. Abstract 16: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necroptosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Cancer Research. 75: 16-16. DOI: 10.1158/1538-7445.Am2015-16 |
0.721 |
|
| 2015 |
Chatterjee P, Choudhary GS, Alswillah T, Xiong X, Heston WD, Magi-Galluzzi C, Zhang J, Klein EA, Almasan A. The TMPRSS2-ERG gene fusion blocks XRCC4-mediated nonhomologous end-joining repair and radiosensitizes prostate cancer cells to PARP inhibition Molecular Cancer Therapeutics. 14: 1896-1906. DOI: 10.1158/1535-7163.MCT-14-0865 |
0.348 |
|
| 2015 |
Choudhary GS, Al-harbi S, Almasan A. Caspase-3 Activation Is a Critical Determinant of Genotoxic Stress-Induced Apoptosis Methods in Molecular Biology. 1219. DOI: 10.1007/978-1-4939-1661-0_1 |
0.323 |
|
| 2014 |
Rosko AE, McColl KS, Zhong F, Ryder CB, Chang MJ, Sattar A, Caimi PF, Hill BT, Al-Harbi S, Almasan A, Distelhorst CW. Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment. Journal of Leukemia (Los Angeles, Calif.). 2. PMID 25984552 DOI: 10.4172/2329-6917.1000160 |
0.651 |
|
| 2014 |
Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells. Cell Death & Disease. 5: e1536. PMID 25412314 DOI: 10.1038/Cddis.2014.500 |
0.722 |
|
| 2014 |
Singh V, Gupta D, Arora R, Tripathi RP, Almasan A, Macklis RM. Surface levels of CD20 determine anti-CD20 antibodies mediated cell death in vitro. Plos One. 9: e111113. PMID 25364827 DOI: 10.1371/Journal.Pone.0111113 |
0.632 |
|
| 2014 |
Sharma A, Janocha AJ, Hill BT, Smith MR, Erzurum SC, Almasan A. Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells. Molecular Cancer Research : McR. 12: 1205-15. PMID 25061101 DOI: 10.1158/1541-7786.Mcr-14-0124 |
0.817 |
|
| 2014 |
Singh K, Sharma A, Mir MC, Drazba JA, Heston WD, Magi-Galluzzi C, Hansel D, Rubin BP, Klein EA, Almasan A. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). Molecular Cancer. 13: 70. PMID 24655592 DOI: 10.1186/1476-4598-13-70 |
0.826 |
|
| 2013 |
Chatterjee P, Plesca D, Mazumder S, Boutros J, Yannone SM, Almasan A. Defective chromatin recruitment and retention of NHEJ core components in human tumor cells expressing a Cyclin E fragment. Nucleic Acids Research. 41: 10157-69. PMID 24021630 DOI: 10.1093/Nar/Gkt812 |
0.714 |
|
| 2013 |
Bodo J, Zhao X, Sharma A, Hill BT, Portell CA, Lannutti BJ, Almasan A, Hsi ED. The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways. British Journal of Haematology. 163: 72-80. PMID 23889282 DOI: 10.1111/Bjh.12498 |
0.817 |
|
| 2013 |
Sharma A, Singh K, Mazumder S, Hill BT, Kalaycio M, Almasan A. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells. Cell Death & Disease. 4: e628. PMID 23681223 DOI: 10.1038/Cddis.2013.155 |
0.836 |
|
| 2013 |
Chatterjee P, Choudhary GS, Sharma A, Singh K, Heston WD, Ciezki J, Klein EA, Almasan A. PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells. Plos One. 8: e60408. PMID 23565244 DOI: 10.1371/Journal.Pone.0060408 |
0.828 |
|
| 2013 |
Zhou N, Singh K, Mir MC, Parker Y, Lindner D, Dreicer R, Ecsedy JA, Zhang Z, Teh BT, Almasan A, Hansel DE. The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1717-28. PMID 23403633 DOI: 10.1158/1078-0432.Ccr-12-2383 |
0.657 |
|
| 2013 |
Chatterjee P, Choudhary GS, Sharma A, Singh K, Heston WD, Ciezki J, Klein EA, Almasan A. Combination of rucaparib with radiation increases χH2AX and 53BP1 foci leading to persistent DNA damage. Plos One. DOI: 10.1371/Journal.Pone.0060408.G003 |
0.789 |
|
| 2013 |
Gupta S, Maria M, Bomalaski J, Elson PJ, Singh K, Harwalkar J, Carver P, Almasan A, Hansel DE. Abstract 11: Arginine deprivation therapy using ADI-PEG20 as a novel therapeutic modality in the treatment of bladder cancer. Cancer Research. 73: 11-11. DOI: 10.1158/1538-7445.Am2013-11 |
0.681 |
|
| 2012 |
Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... Almasan A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490 DOI: 10.4161/Auto.19496 |
0.633 |
|
| 2012 |
Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods in Molecular Biology (Clifton, N.J.). 920: 613-26. PMID 22941631 DOI: 10.1007/978-1-61779-998-3_40 |
0.799 |
|
| 2012 |
Qiu J, Tsien C, Thapalaya S, Narayanan A, Weihl CC, Ching JK, Eghtesad B, Singh K, Fu X, Dubyak G, McDonald C, Almasan A, Hazen SL, Naga Prasad SV, Dasarathy S. Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis. American Journal of Physiology. Endocrinology and Metabolism. 303: E983-93. PMID 22895779 DOI: 10.1152/Ajpendo.00183.2012 |
0.634 |
|
| 2012 |
Mazumder S, Choudhary GS, Al-harbi S, Almasan A. Mcl-1 phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells Cancer Research. 72: 3069-3079. PMID 22525702 DOI: 10.1158/0008-5472.Can-11-4106 |
0.703 |
|
| 2012 |
Bucur O, Stancu AL, Khosravi-Far R, Almasan A. Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications. Cell Death & Disease. 3: e263. PMID 22297295 DOI: 10.1038/Cddis.2012.2 |
0.677 |
|
| 2012 |
Singh K, Matsuyama S, Drazba JA, Almasan A. Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy. 8: 236-51. PMID 22240589 DOI: 10.4161/Auto.8.2.18600 |
0.725 |
|
| 2012 |
Chatterjee P, Choudhary G, Heston WD, Klein EA, Almasan A. Abstract B27: The PARP inhibitor rucaparib radiosensitizes prostate cancer cells, most effectively those that are PTEN-deficient and are expressing ETS gene fusion proteins, which inhibit NHEJ DNA repair Cancer Research. 72: B27-B27. DOI: 10.1158/1538-7445.Prca2012-B27 |
0.709 |
|
| 2011 |
Khan MK, Khan N, Almasan A, Macklis R. Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Oncotargets and Therapy. 4: 137-48. PMID 21949607 DOI: 10.2147/Ott.S20257 |
0.65 |
|
| 2011 |
Al-Harbi S, Hill BT, Mazumder S, Singh K, Devecchio J, Choudhary G, Rybicki LA, Kalaycio M, Maciejewski JP, Houghton JA, Almasan A. An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737. Blood. 118: 3579-90. PMID 21772052 DOI: 10.1182/Blood-2011-03-340364 |
0.673 |
|
| 2011 |
Bodo J, Sedlak J, Maciejewski JP, Almasan A, Hsi ED. HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. Apoptosis : An International Journal On Programmed Cell Death. 16: 914-23. PMID 21667043 DOI: 10.1007/S10495-011-0617-X |
0.696 |
|
| 2011 |
Khan N, Khan MK, Almasan A, Singh AD, Macklis R. The evolving role of radiation therapy in the management of malignant melanoma. International Journal of Radiation Oncology, Biology, Physics. 80: 645-54. PMID 21489712 DOI: 10.1016/J.Ijrobp.2010.12.071 |
0.611 |
|
| 2011 |
Matsuda T, Almasan A, Tomita M, Uchihara JN, Masuda M, Ohshiro K, Takasu N, Yagita H, Ohta T, Mori N. Resistance to Apo2 Ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines (Journal of Virology (2005) 79, 3 (1367-1378)) Journal of Virology. 85. PMID 21228250 DOI: 10.1128/Jvi.02070-10 |
0.676 |
|
| 2011 |
Zhou N, Singh K, Almasan A, Hansel D. Abstract 3599: Aurora kinase inhibitors as a novel targeted drug therapy for bladder cancer Cancer Research. 71: 3599-3599. DOI: 10.1158/1538-7445.Am2011-3599 |
0.678 |
|
| 2010 |
Matsuda T, Almasan A, Tomita M, Tamaki K, Saito M, Tadano M, Yagita H, Ohta T, Mori N. Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand (Journal of General Virology (2005) 86 (1055-1065)) Journal of General Virology. 91. PMID 20847365 DOI: 10.1099/Vir.0.84530-0 |
0.668 |
|
| 2010 |
Almasan A, Singh K, Mazumder S. Abstract 4689: A Cyclin E fragment enhances radiation-induced cell death by modulating autophagy Cancer Research. 70: 4689-4689. DOI: 10.1158/1538-7445.Am10-4689 |
0.72 |
|
| 2010 |
Boutros JA, Plesca D, Mazumder S, Singh K, Almasan A. Abstract 3924: A proteolytic fragment of cyclin E enhances apoptosis by increasing the DNA damage response and inhibiting DNA repair Cancer Research. 70: 3924-3924. DOI: 10.1158/1538-7445.Am10-3924 |
0.715 |
|
| 2010 |
Singh K, Mazumder S, Almasan A. Abstract 130: Molecular basis of autophagy-mediated resistance to radiation and Apo2L/TRAIL therapy of prostate cancer Cancer Research. 70: 130-130. DOI: 10.1158/1538-7445.Am10-130 |
0.719 |
|
| 2009 |
Neznanov N, Gorbachev AV, Neznanova L, Komarov AP, Gurova KV, Gasparian AV, Banerjee AK, Almasan A, Fairchild RL, Gudkov AV. Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications. Cell Cycle (Georgetown, Tex.). 8: 3960-70. PMID 19901558 DOI: 10.4161/Cc.8.23.10179 |
0.675 |
|
| 2009 |
Boutros J, Almasan A. Combining 2-deoxy-D-glucose with electron transport chain blockers: a double-edged sword. Cancer Biology & Therapy. 8: 1237-8. PMID 19458493 DOI: 10.4161/Cbt.8.13.8869 |
0.692 |
|
| 2008 |
Plesca D, Mazumder S, Gama V, Matsuyama S, Almasan A. A C-terminal fragment of Cyclin E, generated by caspase-mediated cleavage, is degraded in the absence of a recognizable phosphodegron. The Journal of Biological Chemistry. 283: 30796-803. PMID 18784078 DOI: 10.1074/Jbc.M804642200 |
0.669 |
|
| 2008 |
Plesca D, Mazumder S, Almasan A. DNA damage response and apoptosis. Methods in Enzymology. 446: 107-22. PMID 18603118 DOI: 10.1016/S0076-6879(08)01606-6 |
0.706 |
|
| 2008 |
Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods in Molecular Biology (Clifton, N.J.). 414: 13-21. PMID 18175808 |
0.331 |
|
| 2008 |
Gupta D, Crosby ME, Almasan A, Macklis RM. Regulation of CD20 expression by radiation-induced changes in intracellular redox status Free Radical Biology and Medicine. 44: 614-623. PMID 18060882 DOI: 10.1016/J.Freeradbiomed.2007.10.048 |
0.628 |
|
| 2007 |
Mazumder S, Plesca D, Almasan A. A jekyll and hyde role of cyclin E in the genotoxic stress response: switching from cell cycle control to apoptosis regulation. Cell Cycle (Georgetown, Tex.). 6: 1437-42. PMID 17581275 DOI: 10.4161/Cc.6.12.4432 |
0.704 |
|
| 2007 |
Plesca D, Crosby ME, Gupta D, Almasan A. E2F4 function in G2: Maintaining G2-arrest to prevent mitotic entry with damaged DNA Cell Cycle. 6: 1147-1152. PMID 17507799 DOI: 10.4161/Cc.6.10.4259 |
0.682 |
|
| 2007 |
Ray S, Shyam S, Fraizer GC, Almasan A. S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells. Molecular Cancer Therapeutics. 6: 1368-78. PMID 17431115 DOI: 10.1158/1535-7163.Mct-05-0414 |
0.715 |
|
| 2007 |
Mazumder S, Plesca D, Kinter M, Almasan A. Interaction of a cyclin E fragment with Ku70 regulates Bax-mediated apoptosis. Molecular and Cellular Biology. 27: 3511-20. PMID 17325036 DOI: 10.1128/Mcb.01448-06 |
0.711 |
|
| 2007 |
Crosby ME, Jacobberger J, Gupta D, Macklis RM, Almasan A. E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma Oncogene. 26: 1897-1909. PMID 17043659 DOI: 10.1038/Sj.Onc.1209998 |
0.721 |
|
| 2006 |
Oancea M, Mazumder S, Crosby ME, Almasan A. Apoptosis assays Methods in Molecular Medicine. 129: 279-290. PMID 17085818 |
0.818 |
|
| 2006 |
Bucur O, Ray S, Bucur MC, Almasan A. APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy. Frontiers in Bioscience : a Journal and Virtual Library. 11: 1549-68. PMID 16368536 |
0.341 |
|
| 2005 |
Ray S, Bucur O, Almasan A. Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor Apoptosis. 10: 1411-1418. PMID 16215673 DOI: 10.1007/S10495-005-2490-Y |
0.713 |
|
| 2005 |
Matsuda T, Almasan A, Tomita M, Tamaki K, Saito M, Tadano M, Yagita H, Ohta T, Mori N. Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. The Journal of General Virology. 86: 1055-65. PMID 15784899 DOI: 10.1099/Vir.0.80531-0 |
0.693 |
|
| 2005 |
Comhair SA, Xu W, Ghosh S, Thunnissen FB, Almasan A, Calhoun WJ, Janocha AJ, Zheng L, Hazen SL, Erzurum SC. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. The American Journal of Pathology. 166: 663-74. PMID 15743779 DOI: 10.1016/S0002-9440(10)62288-2 |
0.666 |
|
| 2005 |
Matsuda T, Almasan A, Tomita M, Uchihara JN, Masuda M, Ohshiro K, Takasu N, Yagita H, Ohta T, Mori N. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines. Journal of Virology. 79: 1367-78. PMID 15650163 DOI: 10.1128/Jvi.79.3.1367-1378.2005 |
0.705 |
|
| 2004 |
Crosby ME, Almasan A. Opposing roles of E2Fs in cell proliferation and death Cancer Biology and Therapy. 3: 1208-1211. PMID 15662116 DOI: 10.4161/Cbt.3.12.1494 |
0.726 |
|
| 2004 |
Oancea M, Mani A, Hussein MA, Almasan A. Apoptosis of multiple myeloma. International Journal of Hematology. 80: 224-31. PMID 15540896 DOI: 10.1532/Ijh97.04107 |
0.819 |
|
| 2004 |
Shi T, Liou LS, Sadhukhan P, Duan ZH, Novick AC, Hissong JG, Almasan A, DiDonato JA. Effects of resveratrol on gene expression in renal cell carcinoma. Cancer Biology & Therapy. 3: 882-8. PMID 15280659 DOI: 10.4161/Cbt.3.9.1056 |
0.663 |
|
| 2004 |
DuPree EL, Mazumder S, Almasan A. Genotoxic stress induces expression of E2F4, leading to its association with p130 in prostate carcinoma cells. Cancer Research. 64: 4390-3. PMID 15231644 DOI: 10.1158/0008-5472.Can-03-3695 |
0.798 |
|
| 2004 |
Liou LS, Shi T, Duan ZH, Sadhukhan P, Der SD, Novick AA, Hissong J, Skacel M, Almasan A, DiDonato JA. Microarray gene expression profiling and analysis in renal cell carcinoma. Bmc Urology. 4: 9. PMID 15212686 DOI: 10.1186/1471-2490-4-9 |
0.624 |
|
| 2004 |
Crosby ME, Oancea M, Almasan A. p53 binding to target sites is dynamically regulated before and after ionizing radiation-mediated DNA damage Journal of Environmental Pathology, Toxicology and Oncology. 23: 67-79. PMID 14994997 DOI: 10.1615/Jenvpathtoxoncol.V23.I1.70 |
0.794 |
|
| 2004 |
Mazumder S, DuPree EL, Almasan A. A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Current Cancer Drug Targets. 4: 65-75. PMID 14965268 DOI: 10.2174/1568009043481669 |
0.809 |
|
| 2004 |
Zheng Y, Shi Y, Tian C, Jiang C, Jin H, Chen J, Almasan A, Tang H, Chen Q. Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide. Oncogene. 23: 1239-47. PMID 14647451 DOI: 10.1038/Sj.Onc.1207205 |
0.651 |
|
| 2003 |
Chen Q, Crosby M, Almasan A. Redox Regulation of Apoptosis before and after Cytochrome C Release. Korean Journal of Biological Sciences. 7: 1-9. PMID 16467897 DOI: 10.1080/12265071.2003.9647675 |
0.698 |
|
| 2003 |
Masri SC, Yamani MH, Russell MA, Ratliff NB, Yang J, Almasan A, Apperson-Hansen C, Li J, Starling RC, McCarthy P, Young JB, Bond M. Sustained apoptosis in human cardiac allografts despite histologic resolution of rejection. Transplantation. 76: 859-64. PMID 14501868 DOI: 10.1097/01.Tp.0000084824.70320.Da |
0.671 |
|
| 2003 |
Chen Q, Ray S, Hussein MA, Srkalovic G, Almasan A. Role of Apo2L/TRAIL and Bcl-2-family proteins in apoptosis of multiple myeloma. Leukemia & Lymphoma. 44: 1209-14. PMID 12916874 DOI: 10.1080/1042819031000068052 |
0.713 |
|
| 2003 |
Chawla-Sarkar M, Bauer JA, Lupica JA, Morrison BH, Tang Z, Oates RK, Almasan A, DiDonato JA, Borden EC, Lindner DJ. Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL. The Journal of Biological Chemistry. 278: 39461-9. PMID 12881518 DOI: 10.1074/Jbc.M306111200 |
0.69 |
|
| 2003 |
Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine & Growth Factor Reviews. 14: 337-48. PMID 12787570 DOI: 10.1016/S1359-6101(03)00029-7 |
0.707 |
|
| 2003 |
Chen Q, Chai YC, Mazumder S, Jiang C, Macklis RM, Chisolm GM, Almasan A. The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction Cell Death and Differentiation. 10: 323-334. PMID 12700632 DOI: 10.1038/Sj.Cdd.4401148 |
0.67 |
|
| 2002 |
Mazumder S, Almasan A. Is caspase-8 a neuroendocrine lung tumor suppressor? Cancer Biology & Therapy. 1: 70-1. PMID 12197486 DOI: 10.4161/Cbt.1.1.46 |
0.6 |
|
| 2002 |
Morrison BH, Bauer JA, Hu J, Grane RW, Ozdemir AM, Chawla-Sarkar M, Gong B, Almasan A, Kalvakolanu DV, Lindner DJ. Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. Oncogene. 21: 1882-9. PMID 11896621 DOI: 10.1038/Sj.Onc.1205265 |
0.675 |
|
| 2002 |
Mazumder S, Gong B, Chen Q, Drazba JA, Buchsbaum JC, Almasan A. Proteolytic cleavage of cyclin E leads to inactivation of associated kinase activity and amplification of apoptosis in hematopoietic cells. Molecular and Cellular Biology. 22: 2398-409. PMID 11884622 DOI: 10.1128/Mcb.22.7.2398-2409.2002 |
0.691 |
|
| 2001 |
Chen Q, Gong B, Mahmoud-Ahmed AS, Zhou A, Hsi ED, Hussein M, Almasan A. Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood. 98: 2183-92. PMID 11568006 DOI: 10.1182/Blood.V98.7.2183 |
0.699 |
|
| 2001 |
Masri SC, Yamani MH, Ratliff NB, Almasan A, Fink M, Young JB, Starling RC, Bond M. Apoptosis in cardiac allograft rejection and its response to treatment. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 20: 227. PMID 11250429 DOI: 10.1016/S1053-2498(00)00504-0 |
0.624 |
|
| 2001 |
Almasan A, Gong B, Ray S, Kupelian P, Klein E, Heston W, Macklis R, Buchsbaum J. Global response to radiation in prostate adenocarcinoma: examination of 12,000 genes and 48,000 ESTs following fractionated versus bolus radiation International Journal of Radiation Oncology*Biology*Physics. 51: 225. DOI: 10.1016/S0360-3016(01)02233-7 |
0.677 |
|
| 2000 |
Gong B, Almasan A. Genomic organization and transcriptional regulation of human Apo2/TRAIL gene Biochemical and Biophysical Research Communications. 278: 747-752. PMID 11095979 DOI: 10.1006/Bbrc.2000.3872 |
0.66 |
|
| 2000 |
Mazumder S, Gong B, Almasan A. Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells Oncogene. 19: 2828-2835. PMID 10851086 DOI: 10.1038/Sj.Onc.1203623 |
0.709 |
|
| 2000 |
Chen Q, Gong B, Almasan A. Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell Death and Differentiation. 7: 227-33. PMID 10713737 DOI: 10.1038/Sj.Cdd.4400629 |
0.645 |
|
| 2000 |
Almasan A. Cellular commitment to radiation-induced apoptosis. Radiation Research. 153: 347-50. PMID 10669558 DOI: 10.1667/0033-7587(2000)153[0347:Cctria]2.0.Co;2 |
0.689 |
|
| 1998 |
Gong B, Chen Q, Almasan A. Ionizing radiation stimulates mitochondrial gene expression and activity Radiation Research. 150: 505-512. PMID 9806591 DOI: 10.2307/3579866 |
0.644 |
|
| 1998 |
Paulson TG, Almasan A, Brody LL, Wahl GM. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Molecular and Cellular Biology. 18: 3089-100. PMID 9566927 DOI: 10.1128/Mcb.18.5.3089 |
0.686 |
|
| 1997 |
Almasan A, Gong B, Goss V, Jiang X. 87 BCL-2 activation by ionizing radiation in a glioblastoma cell line International Journal of Radiation Oncology*Biology*Physics. 39: 178. DOI: 10.1016/S0360-3016(97)80645-1 |
0.658 |
|
| 1995 |
Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li W, Bertino JR, Wahl GM. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 92: 5436-40. PMID 7777526 DOI: 10.1073/Pnas.92.12.5436 |
0.67 |
|
| 1995 |
Almasan A, Linke SP, Paulson TG, Huang LC, Wahl GM. Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer Metastasis Reviews. 14: 59-73. PMID 7606822 DOI: 10.1007/Bf00690212 |
0.698 |
|
| 1995 |
Li W, Fan J, Hochhauser D, Banerjee D, Zielinski Z, Almasan A, Yin Y, Kelly R, Wahl GM, Bertino JR. Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proceedings of the National Academy of Sciences of the United States of America. 92: 10436-40. PMID 7479800 DOI: 10.1073/Pnas.92.22.10436 |
0.67 |
|
| 1995 |
Endlich BP, Almasan A, Macklis RM. 161 Prolonged G2 delay in murine lymphoma cells susceptible to radiation-induced apoptosis correlates with cyclin B1 expression International Journal of Radiation Oncology*Biology*Physics. 32: 221. DOI: 10.1016/0360-3016(95)97824-K |
0.689 |
|
| 1994 |
Almasan A, Mangelsdorf DJ, Ong ES, Wahl GM, Evans RM. Chromosomal localization of the human retinoid X receptors. Genomics. 20: 397-403. PMID 8034312 DOI: 10.1006/Geno.1994.1193 |
0.576 |
|
| 1991 |
Almasan A, Mishra NC. Recombination by sequence repeats with formation of suppressive or residual mitochondrial DNA in Neurospora. Proceedings of the National Academy of Sciences of the United States of America. 88: 7684-8. PMID 1881910 DOI: 10.1073/Pnas.88.17.7684 |
0.743 |
|
| 1990 |
Almasan A, Mishra NC. Characterization of a novel plasmid-like element in Neurospora crassa derived mostly from the mitochondrial DNA. Nucleic Acids Research. 18: 5871-7. PMID 2145549 DOI: 10.1093/Nar/18.19.5871 |
0.74 |
|
| 1990 |
Mishra NC, Almasan A, Cooley M. Characterization of eukaryotic DNA polymerases: aphidicolin resistant mutants of Neurospora with altered DNA polymerase Progress in Clinical and Biological Research. 344: 295-313. PMID 2144049 |
0.616 |
|
| 1988 |
Almasan A, Mishra NC. Molecular characterization of the mitochondrial DNA of a new stopper mutant ER-3 of Neurospora crassa. Genetics. 120: 935-45. PMID 2976009 |
0.598 |
|
| Show low-probability matches. |